Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: Potential pitfalls in the transition from intravenous to oral therapy

Journal of Clinical Microbiology

Volumn 43, Issue 2, 2005, Pages 973-977

  Schaenman, Joanna M ^a   DiGiulio, Daniel B ^a   Mirels, Laurence F ^a,b   McClenny, Nancy M ^a   Berry, Gerald J ^a   Fothergill, Annette W ^d   Rinaldi, Michael G ^d   Montoya, Jose G ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; CASPOFUNGIN; INFLIXIMAB; ITRACONAZOLE; OXACILLIN; PREDNISONE; TERBINAFINE; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; DOSE CALCULATION; DRUG CHOICE; DRUG EFFICACY; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PRIORITY JOURNAL; SCEDOSPORIUM APIOSPERMUM; SOFT TISSUE INFECTION;

ADMINISTRATION, ORAL; ANTIFUNGAL AGENTS; ARM; FEMALE; HAND; HUMANS; INJECTIONS, INTRAVENOUS; MADUROMYCOSIS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PYRIMIDINES; SCEDOSPORIUM; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME; TRIAZOLES;

PSEUDALLESCHERIA BOYDII; SCEDOSPORIUM;

EID: 13844266077     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.2.973-977.2005     Document Type: Article

References (47)

1. Baden, L. R., J. T. Katz, J. A. Fishman, C. Koziol, A. DelVecchio, M. Doran, and R. H. Rubin. 2003. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation 76:1632-1637.
2. Barbaric, D., and P. J. Shaw. 2001. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole. Med. Pediatr. Oncol. 37:122-125.
3. Bosma, F., A. Voss, H. W. van Hamersvelt, R. G. de Sevaux, J. Biert, B. J. Kullberg, W. G. Melchers, and P. E. Verweij. 2003. Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole. Clin. Microbiol. Infect. 9:750-753.
4. Bower, C. P., J. D. Oxley, C. K. Campbell, and C. B. Archer. 1999. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient. J. Clin. Pathol. 52:846-848.
5. Canet, J. J., X. Pagerols, C. Sanchez, P. Vives, and J. Garau. 2001. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin. Microbiol. Infect. 7:648-650.
6. Capilla, J., C. Serena, F. J. Pastor, M. Ortoneda, and J. Guarro. 2003. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob. Agents Chemother. 47:3976-3978.
7. Chaveiro, M. A., R. Vieira, J. Cardoso, and A. Afonso. 2003. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient. J. Eur. Acad. Dermatol. Venereol. 17:47-49.
8. Cuenca-Estrella, M., B. Ruiz-Diez, J. V. Martinez-Suarez, A. Monzon, and J. L. Rodriguez-Tudela. 1999. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J. Antimicrob. Chemother. 43:149-151.
9. Cunningham, R., and D. C. Mitchell. 1996. Amphotericin B responsive Scedosporium apiospermum infection in a patient with acute myeloid leukaemia. J. Clin. Pathol. 49:93-94.
10. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571.
11. Ellis, D. 2002. Amphotericin B: spectrum and resistance. J. Antimicrob. Chemother. 49(Suppl. 1):7-10.
12. Espinel-Ingroff, A. 2001. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J. Clin. Microbiol. 39:954-958.
13. Ginter, G., B. Petutschnig, G. Pierer, H. P. Soyer, S. Reischle, T. Kern, and S. de Hoog. 1999. Case report. Atypical cutaneous pseudallescheriosis refractory to antifungal agents. Mycoses 42:507-511.
14. Girmenia, C., G. Luzi, M. Monaco, and P. Martino. 1998. Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J. Clin. Microbiol. 36:1436-1438.
15. Heller, H. M., and M. N. Swartz. 1994. Nodular lymphangitis: clinical features, differential diagnosis and management. Curr. Clin. Top. Infect. Dis. 14:142-158.
16. Herbrecht, R., D. W. Denning, T. F. Patterson, J. E. Bennett, R. E. Greene, J. W. Oestmann, W. V. Kern, K. A. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. H. Rubin, J. R. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. H. Chandrasekar, M. R. Hodges, H. T. Schlamm, P. F. Troke, and B. de Pauw. 2002. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. 347:408-415.
17. Ichikawa, T., M. Saiki, S. Tokunaga, and T. Saida. 1997. Scedosporium apiospermum skin infection in a patient with nephrotic syndrome. Acta Derm. Venereol. 77:172-173.
18. Johnson, L. B., and C. A. Kauffman. 2003. Voriconazole: a new triazole antifungal agent. Clin. Infect. Dis. 36:630-637.
19. Kappe, R. 1999. Antifungal activity of the new azole UK-109,496 (voriconazole). Mycoses 42:83-86.
20. Karaarslan, A., S. Arikan, F. Karaarslan, and E. S. Cetin. 2003. Skin infection caused by Scedosporium apiospermum. Mycoses 46:524-526.
21. Kim, H. U., S. C. Kim, and H. S. Lee. 1999. Localized skin infection due to Scedosporium apiospermum: report of two cases. Br. J. Dermatol. 141:605-606.
22. Klopfenstein, K. J., R. Rosselet, A. Termuhlen, and D. Powell. 2003. Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation. Med. Pediatr. Oncol. 41:494-495.
23. Kusuhara, M., and H. Hachisuka. 1997. Lymphocutaneous infection due to Scedosporium apiospermum. Int. J. Dermatol. 36:684-688.
24. Kwon-Chung, K., and J. Bennett. 1992. Pseudallescheriasis and Scedosporium infection, p. 678-694. In Medical mycology. Lea & Febiger, Philadelphia, Pa.
25. Lavigne, C., F. Maillot, A. de Muret, M. Therizol-Ferly, F. Lamisse, and L. Machet. 1999. Cutaneous infection with Scedosporium apiospermum in a patient treated with corticosteroids. Acta Dermatol. Venereol. 79:402-403.
26. Lazarus, H. S., J. P. Myers, and R. J. Brocker. 1986. Post-craniotomy wound infection caused by Pseudallescheria boydii: case report. J. Neurosurg. 64:153-154.
27. Liu, Y. F., X. D. Zhao, C. L. Ma, C. X. Li, T. S. Zhang, and W. J. Liao. 1997. Cutaneous infection by Scedosporium apiospermum and its successful treatment with itraconazole. Clin. Exp. Dermatol. 22:198-200.
28. Lopes, J. O., S. H. Alves, J. P. Benevenga, A. Salla, C. Khmohan, and C. B. Silva. 1994. Subcutaneous pseudallescheriasis in a renal transplant recipient. Mycopathologia 125:153-156.
29. Lopez, F. A., R. S. Crowley, L. Wastila, H. A. Valantine, and J. S. Remington. 1998. Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity. J. Heart Lung Transplant. 17:321-324.
30. Miele, P. S., C. S. Levy, M. A. Smith, E. M. Dugan, R. H. Cooke, J. A. Light, and D. R. Lucey. 2002. Primary cutaneous fungal infections in solid organ transplantation: a case series. Am. J. Transplant. 2:678-683.
31. Miyamoto, T., R. Sasaoka, M. Kawaguchi, S. Ishioka, T. Inoue, N. Yamada, and M. Mihara. 1998. Scedosporium apiospermum skin infection: a case report and review of the literature. J. Am. Acad. Dermatol. 39:498-500.
32. Montejo, M., M. L. Muniz, S. Zarraga, K. Aguirrebengoa, J. J. Amenabar, L. Lopez-Soria, and R. Gonzalez. 2002. Infection due to Scedosporium apiospermum in renal transplant recipients: a report of two cases and literature review of central nervous system and cutaneous infections by Pseudallescheria boydii/Sc, apiospermum. Mycoses 45:418-427.
33. Munoz, P., M. Marin, P. Tornero, P. Martin Rabadan, M. Rodriguez-Creixems, and E. Bouza. 2000. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin. Infect. Dis. 31:1499-1501.
34. Nesky, M. A., E. C. McDougal, and J. E. Peacock, Jr. 2000. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin. Infect. Dis. 31:673-677.
35. Nonaka, D., H. Yfantis, P. Southall, and C. C. Sun. 2002. Pseudallescheriasis as an aggressive opportunistic infection in a bone marrow transplant recipient. Arch. Pathol. Lab. Med. 126:207-209.
36. Nulens, E., C. Eggink, A. J. Rijs, P. Wesseling, and P. E. Verweij. 2003. Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole. J. Clin. Microbiol. 41:2261-2264.
37. Ochiai, N., C. Shimazaki, R. Uchida, S. Fuchida, A. Okano, E. Ashihara, T. Inaba, N. Fujita, and M. Nakagawa. 2003. Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia. Leuk. Lymphoma 44:369-372.
38. Patterson, T. F., V. T. Andriole, M. J. Zervos, D. Therasse, and C. A. Kauffman. 1990. The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses 33:297-302.
39. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
40. Pether, J. V., W. Jones, F. B. Greatorex, and W. Bunting. 1992. Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole. J. Infect. 25:335-336.
41. Reimann, D., E. Bussemaker, and P. Gross. 2004. Successful treatment due to vacuum seal technique of a severe Scedosporium apiospermum skin infection in a renal transplant recipient. Nephrol. Dial. Transplant. 19:245-248.
42. Ruxin, T. A., W. D. Steck, T. N. Helm, W. F. Bergfeld, and B. J. Bolwell. 1996. Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole. Arch. Dermatol. 132:382-384.
43. Severo, L. C., M. Oliveira Fde, and A. T. Londero. 1997. Subcutaneous scedosporiosis: report of two cases and review of the literature. Rev. Inst. Med. Trop. Sao Paulo 39:227-230.
44. Sheftel, T. G., J. T. Mader, and G. Cierny. 1987. Pseudoallescheria boydii soft tissue abscess. Clin. Orthop. 215:212-216.
45. Steinbach, W. J., and J. R. Perfect. 2003. Scedosporium species infections and treatments. J. Chemother. 15(Suppl. 2):16-27.
46. Torok, L., G. Simon, A. Csornai, M. Tapai, and I. Torok. 1995. Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukaemia. Br. J. Dermatol. 133:805-809.
47. Walsh, T. J., I. Lutsar, T. Driscoll, B. Dupont, M. Roden, P. Ghahramani, M. Hodges, A. H. Groll, and J. R. Perfect. 2002. Voriconazole in the treatment of aspergillosis, scedosporiosis, and other invasive fungal infections in children. Pediatr. Infect. Dis. J. 21:240-248.